Intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: An adaptive randomized controlled non-inferiority trial

Trial Profile

Intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: An adaptive randomized controlled non-inferiority trial

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 25 Jun 2015

At a glance

  • Drugs Amphotericin B liposomal (Primary) ; Fluconazole
  • Indications Cryptococcal meningitis
  • Focus Therapeutic Use
  • Acronyms AMBITION-cm
  • Most Recent Events

    • 27 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top